During the past decade, People's Hospital of Deyang City conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "People's Hospital of Deyang City" #1 sponsor was "Bayer" with 2 trials, followed by "Sichuan Cancer Hospital and Research Institute" with 2 trials sponsored, "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 1 trials sponsored, "Ark Biosciences Inc." with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "People's Hospital of Deyang City" #1 collaborator was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials as a collaborator, "Beijing Hospital" with 1 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials as a collaborator, "Chongqing University Cancer Hospital" with 1 trials as a collaborator and "First Affiliated Hospital of Chongqing Medical University" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "People's Hospital of Deyang City" are "Lung Cancer Metastatic" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Atrial Fibrillation" (1 trials), "Colorectal Cancer" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "People's Hospital of Deyang City" in a lesser frequency.

Most popular intervention types in "People's Hospital of Deyang City" are "Drug" (9 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AK0529" (1 trials), "Anlotinib Hydrochloride" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "People's Hospital of Deyang City" are 9 trials for "All" genders.

Currently, there are NaN active trials in "People's Hospital of Deyang City". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in People's Hospital of Deyang City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in People's Hospital of Deyang City, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".